v3.26.1
Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
$ in Thousands
Common Stock
Previously Reported
Common Stock
Retroactive application of Merger
Common Stock
Preferred Stock
Previously Reported
Series A
Preferred Stock
Previously Reported
Series A
Preferred Stock
Previously Reported
Preferred Stock
Retroactive application of Merger
Series A
Preferred Stock
Retroactive application of Merger
Series A
Preferred Stock
Retroactive application of Merger
Preferred Stock
Series A
Preferred Stock
Additional Paid in Capital
Previously Reported
Additional Paid in Capital
Retroactive application of Merger
Additional Paid in Capital
Accumulated Deficit
Previously Reported
Accumulated Deficit
Retroactive application of Merger
Accumulated Deficit
Accumulated Other Comprehensive Income
Previously Reported
Accumulated Other Comprehensive Income
Retroactive application of Merger
Accumulated Other Comprehensive Income
Previously Reported
Retroactive application of Merger
Total
Beginning Balance at Dec. 31, 2023 $ 4 $ 4     $ 29,241 $ (4) $ 29,237 $ (26,173) $ (26,173) $ 140 $ 140 $ 3,208 $ 3,208
Beginning Balance (in Shares) at Dec. 31, 2023 773,753 38,893,272 39,667,025 655,351   106,159 (655,351)   (106,159)                            
Exercise of stock options                                
Exercise of stock options (in Shares)     4,857                                        
Issuance of common stock upon conversion of preferred stock in connection with the Merger                     609             609
Issuance of common stock upon conversion of preferred stock in connection with the Merger (in Shares)     229,900                                        
Stock based compensation                     112             112
Foreign currency translation adjustments                             (18)     (18)
Net loss                         (994)         (994)
Ending Balance at Dec. 31, 2024 $ 4 $ 4     $ 29,962 $ (4) 29,958 $ (27,167)   (27,167) $ 122   122 $ 2,917 2,917
Ending Balance (in Shares) at Dec. 31, 2024 773,941 39,127,841 39,901,782 655,351   115,057 (655,351)   (115,057)                            
Exercise of stock options     $ 1                 435             436
Exercise of stock options (in Shares)     4,404,814                                        
Shares issued in reverse acquisition                     (176)             (176)
Shares issued in reverse acquisition (in Shares)     2,250,000                                        
Shares issued in private placement offering, net of Offering costs     $ 1                 28,847             28,848
Shares issued in private placement offering, net of Offering costs (in Shares)     11,012,387                                        
Stock based compensation                     473             473
Treasury stock                       (81)             (81)
Treasury stock (in Shares)     (26,870)                                        
Foreign currency translation adjustments                             115     115
Net loss                         (5,336)         (5,336)
Ending Balance at Dec. 31, 2025     $ 6                 $ 59,456     $ (32,503)     $ 237     $ 27,196
Ending Balance (in Shares) at Dec. 31, 2025     57,542,113